As World Tuberculosis Day or World TB Day approaches on March 24th, it’s important to remember that tuberculosis (TB) remains a significant global health issue. Prior to the COVID-19 pandemic, TB was the leading cause of death from a single infectious agent, ranking above HIV/AIDS.  The United States has one of the lowest TB incidence rates in the world, however, there is not a single country in the world that has successfully eliminated the disease entirely.  

Despite being a preventable and curable disease, TB still claims the lives of millions of people worldwide each year. In light of this, healthcare providers must stay up to date on the latest clinical practice guidelines for TB treatment and management to provide the best care possible for their patients.

In this article, we’ll delve into the clinical practice guidelines surrounding TB and review the recommendations from various medical societies to help educate clinicians on the most effective recommendation strategies for managing this disease.

Tuberculosis Screening & Assessment Guidelines

Tuberculosis Diagnosing & Treating Guidelines

  • Treatment of Drug-Resistant Tuberculosis
    • Society:American Thoracic Society (ATS), Centers for Disease Control & Prevention (CDC), European Respiratory Society (ERS) & Infectious Diseases Society of America(IDSA)
    • Published:November2019

TuberculosisPharmacotherapy-Related Considerations

Tuberculosis Guidance for Specialized Patient Populations &/or Comorbidities

Tuberculosis Prevention Guidelines

Successfully treating TB requires multiple medications to be taken by the patient over the course of several months.  Remaining vigilant to assessing for signs and symptoms of tuberculosis infections, screening promptly, initiating therapy, and involving the patient in their healthcare decisions in a meaningful way is one way you can do your part as a clinician to continue eradicating TB in the United States.

Copyright © 2023 Guideline Central, All rights reserved.